Mindpeak

Mindpeak is a Hamburg-based company that develops artificial intelligence software for clinical pathology and histopathology image analysis. Its products are designed to assist pathologists in detecting, classifying, and quantifying biomarkers in tissue samples, with the goal of making pathological diagnosis faster and more reproducible. Mindpeak serves clinical diagnostic laboratories, translational research teams, and clinical trial services, and positions its AI tools as a response to growing demand for expert histopathology evaluation against a backdrop of a relatively static number of practicing pathologists worldwide.

The company operates across three broad application areas: clinical diagnostics, where it develops AI-powered diagnostic software and integrates algorithms into histology-based in vitro diagnostics (IVDs) including companion diagnostics; translational research, where its AI identifies clinically relevant predictive biomarkers to support treatment decisions and patient stratification; and clinical trial services, where its AI is used to stratify patients into trials and quantify biomarkers for correlative studies in prospective clinical trials.

Product Suite

• Mindpeak Gastric PD-L1: A 0-click AI solution to detect and quantify programmed death ligand 1 (PD-L1) in gastric cancer tissue using IHC.
• Mindpeak Urothel PD-L1: A 0-click solution to detect and quantify PD-L1 in urothelial carcinoma.
• Mindpeak Esophagus PD-L1: A 0-click AI solution to detect and quantify PD-L1 in esophageal squamous cell carcinoma samples.
• Mindpeak Lung (NSCLC) PD-L1: A 0-click AI model designed to assist in detecting invasive carcinoma regions and scoring PD-L1 positive and negative tumor cells in non-small cell lung cancer tissue samples.
• Mindpeak Breast Metastasis Detection: An H&E-based AI tool that finds metastases in breast lymph node sections using image analysis.
• Mindpeak Breast HER2: A 0-click AI solution to detect and quantify HER2 in breast cancer tissue.
• Mindpeak Breast HER2 RoI: A plug-and-play AI solution to detect and quantify HER2 within predefined regions of interest (RoIs) in breast cancer tissue.
• Mindpeak Breast Ki-67 HS: A 0-click AI solution to detect and quantify Ki-67 in tumor regions of interest according to the hotspot method.
• Mindpeak Breast Ki-67 4R: A 0-click AI solution to detect and quantify Ki-67 in up to four tumor regions of interest according to the global scoring method.
• Mindpeak Breast ER/PR: A 0-click AI solution to detect and quantify estrogen receptor and progesterone receptor (ER/PR) in breast cancer cells.
• Mindpeak Breast H&E: A 0-click solution for the detection of invasive breast cancer tissue using H&E staining.
• Mindpeak Prostate H&E: A standalone software module for automated image analysis of digital histopathology images of prostate cancer tissue, including detection and scoring of prostate cancer patterns.
• Mindpeak Onychomycosis AI: Described as the first commercial dermatopathology AI solution to detect nail fungus hypha using PAS staining.

Core Capabilities and Technology

• Mindpeak's products are built around a 0-click workflow, meaning that upon opening a whole slide image (WSI), the AI automatically identifies and segments tissue, identifies tumor areas, detects and classifies tumor cells, and proposes scored hotspots without requiring manual initiation by the pathologist.
• The automated pipeline includes tumor identification and precalculation steps, with results available for detailed review by the pathologist.
• Products are designed to provide highly reproducible diagnoses and to reduce the need for pathologists to perform repetitive, time-consuming quantification tasks.
• The AI tools support storage of regions of interest, cell counts, and clinical scores within integrated partner software environments.

Deployment and Integration

• Mindpeak offers two deployment modes: deep integration into partner digital pathology software platforms, and a standalone AI Console that allows users to upload images or insert screenshots for AI analysis.
• Deep integrations are designed to embed Mindpeak's algorithms directly into the pathologist's existing workflow within partner software, enabling seamless availability of AI tools and the full 0-click experience.
• The standalone Mindpeak AI Console is CE-marked and is described as optimised for on-screen display and interpretability of image data.
• Integration partners include Clinsight, Roche, Philips, Siemens Healthineers, Proscia, Gestalt Diagnostics, ZEISS, Paige, Sectra, and PathPresenter Corporation.
• Mindpeak has a distribution partnership with Paige, through which pathologists can access Mindpeak's BreastIHC AI software within the Paige Platform for real-time results on routine breast cancer IHC biomarkers.
• Mindpeak has announced a global reseller agreement with Leica Biosystems.

Company Background and Leadership

• Mindpeak is headquartered in Hamburg, Germany, and describes its AI as developed in Germany for laboratories worldwide.
• The company was co-founded by CEO Felix Faber, a computer scientist and entrepreneur who previously founded Bytro Labs and merged it with Stillfront Group, and CTO Dr. Tobias Lang, a data scientist and machine learning expert with research experience at Zalando, SCR Princeton, and the University of Hamburg, who holds a PhD from FU Berlin.
• Other leadership includes a Head of Operations with BCG and private equity experience, a VP of Precision Medicine with a PhD in Molecular Medicine, a VP of Engineering with over 21 years of IT industry experience, and a Chief Pathologist who is a former resident pathologist at University Erlangen with expertise in breast, gynaecological, and uropathology.
• The company's advisory board includes pathologists and life sciences executives from institutions such as Emory University School of Medicine, Queen's University Belfast, Friedrich-Alexander Universität Erlangen, the Institute of Haematopathology Hamburg, and the Institute of Pathology Celle, as well as industry figures with backgrounds at Philips Healthcare, Definiens, and Discovery Life Sciences.
• Mindpeak has participated in events including AACR 2026 in collaboration with Revolune, and has been featured in Oncology Times.

Mindpeak's products are used by clinical pathology laboratories and are cited by pathologists such as PD Dr. med. habil. Ramona Erber of Universitätsklinikum Erlangen for enabling efficient and reproducible biomarker evaluation. The company states it has advised members of the German parliament on AI in pathology.